Moxonidine
Title: Moxonidine
CAS Registry Number: 75438-57-2
CAS Name: 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine
Additional Names: 4-chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrimidine
Manufacturers' Codes: BDF-5895
Trademarks: Cynt (Beiersdorf); Physiotens (Giulini)
Molecular Formula: C9H12ClN5O
Molecular Weight: 241.68
Percent Composition: C 44.73%, H 5.00%, Cl 14.67%, N 28.98%, O 6.62%
Literature References: a2-Adrenoceptor agonist. Prepn: NL 7908192; W. Stenzel et al., US 4323570 (1980, 1982 both to Beiersdorf AG). Series of articles on pharmacology and binding studies: Arzneim.-Forsch. 38, 1426-1445 (1988). Pharmacokinetics: D. Trenk et al., J. Clin. Pharmacol. 27, 988 (1987); W. Kirch et al., ibid. 30, 1088 (1990). Clinical comparison with clonidine, q.v.: V. Plänitz, ibid. 27, 46 (1987).
Properties: mp 217-219° (dec).
Melting point: mp 217-219° (dec)
 
Derivative Type: Hydrochloride
CAS Registry Number: 75438-58-3
Properties: Crystals from isopropanol/ether, mp 189°.
Melting point: mp 189°
 
Therap-Cat: Antihypertensive.
Keywords: a-Adrenergic Agonist; Antihypertensive; Imidazole Derivatives.

Others monographs:
IbudilastIsobutyl IsobutyratePyroligneous AcidCy 3
SafinamideReticulinXylyl BromideBifenthrin
Methyl Benzoate4-Amino-2-sulfobenzoic AcidProsultiamine11-Desoxy-17-hydroxycorticosterone
TuftsinAgomelatineEtoperidoneDita Bark
©2016 DrugLead US FDA&EMEA